Adenovirus-based vaccines against avian-origin H5N1 influenza viruses

Microbes Infect. 2015 Feb;17(2):135-41. doi: 10.1016/j.micinf.2014.11.003. Epub 2014 Dec 3.

Abstract

Since 1997, human infection with avian H5N1, having about 60% mortality, has posed a threat to public health. In this review, we describe the epidemiology of H5N1 transmission, advantages and disadvantages of different influenza vaccine types, and characteristics of adenovirus, finally summarizing advances in adenovirus-based H5N1 systemic and mucosal vaccines.

Keywords: Adenovirus; H5N1; Mucosal; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenoviridae / immunology*
  • Animals
  • Birds
  • China / epidemiology
  • Communicable Disease Control
  • Humans
  • Influenza A Virus, H5N1 Subtype / immunology*
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / immunology*
  • Influenza in Birds / virology*
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Influenza, Human / transmission
  • Influenza, Human / virology

Substances

  • Influenza Vaccines